Gocl [GOCLCORP] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison
Gocl
NSE
Loading...
Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Gocl wins in 10 metrics, Grauer & Weil wins in 8 metrics, with 0 ties. Gocl appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Gocl | Grauer & Weil | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.09 | 26.73 | Gocl |
| Price-to-Book Ratio | 1.12 | 4.48 | Gocl |
| Debt-to-Equity Ratio | 70.75 | 1.26 | Grauer & Weil |
| PEG Ratio | N/A | 37.25 | N/A |
| EV/EBITDA | 10.50 | 20.89 | Gocl |
| Profit Margin (TTM) | 259.04% | 13.35% | Gocl |
| Operating Margin (TTM) | 88.52% | 18.36% | Gocl |
| EBITDA Margin (TTM) | 88.52% | 18.36% | Gocl |
| Return on Equity | 9.97% | 16.73% | Grauer & Weil |
| Return on Assets (TTM) | 5.06% | 12.23% | Grauer & Weil |
| Free Cash Flow (TTM) | $9.30M | $999.80M | Grauer & Weil |
| Dividend Yield | 3.55% | 1.05% | Gocl |
| 1-Year Return | -18.72% | -0.82% | Grauer & Weil |
| Price-to-Sales Ratio (TTM) | 3.41 | 3.74 | Gocl |
| Enterprise Value | $28.63B | $36.79B | Grauer & Weil |
| EV/Revenue Ratio | 5.16 | 3.27 | Grauer & Weil |
| Gross Profit Margin (TTM) | 19.86% | 41.05% | Grauer & Weil |
| Revenue per Share (TTM) | $105 | $25 | Gocl |
| Earnings per Share (Diluted) | $18.71 | $3.47 | Gocl |
| Beta (Stock Volatility) | N/A | 0.28 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Gocl vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Gocl | -0.25% | 5.03% | -9.49% | 23.89% | 11.30% | -4.51% |
| Grauer & Weil | 0.11% | -2.32% | -11.54% | 9.08% | 6.92% | -11.88% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Gocl | -18.72% | 22.19% | 95.03% | 143.92% | 308.11% | 52.89% |
| Grauer & Weil | -0.82% | 39.06% | 116.96% | 385.60% | 953.98% | 726.65% |
Performance & Financial Health Analysis: Gocl vs Grauer & Weil
| Metric | GOCLCORP | GRAUWEIL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹17.70B | ₹42.05B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 76,862 | 141,218 |
| 90 Day Avg. Volume | 102,275 | 163,561 |
| Last Close | ₹356.20 | ₹92.85 |
| 52 Week Range | ₹245.00 - ₹516.80 | ₹78.00 - ₹120.00 |
| % from 52W High | -31.08% | -22.63% |
| All-Time High | ₹699.55 (Jan 22, 2018) | ₹204.80 (Feb 26, 2024) |
| % from All-Time High | -49.08% | -54.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.50% | -0.04% |
| Quarterly Earnings Growth | 32.73% | -0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 2.59% | 0.13% |
| Operating Margin (TTM) | 0.89% | 0.18% |
| Return on Equity (TTM) | 0.10% | 0.17% |
| Debt to Equity (MRQ) | 70.75 | 1.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹318.00 | ₹20.72 |
| Cash per Share (MRQ) | N/A | ₹11.87 |
| Operating Cash Flow (TTM) | ₹1.85B | ₹1.68B |
| Levered Free Cash Flow (TTM) | ₹1.57B | ₹1.57B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.55% | 1.05% |
| Last 12-Month Dividend | ₹14.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Gocl vs Grauer & Weil
| Metric | GOCLCORP | GRAUWEIL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.09 | 26.73 |
| Forward P/E | N/A | 37.25 |
| PEG Ratio | N/A | 37.25 |
| Price to Sales (TTM) | 3.41 | 3.74 |
| Price to Book (MRQ) | 1.12 | 4.48 |
| Market Capitalization | ||
| Market Capitalization | ₹17.70B | ₹42.05B |
| Enterprise Value | ₹28.63B | ₹36.79B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.16 | 3.27 |
| Enterprise to EBITDA | 10.50 | 20.89 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.28 |
| Book Value per Share (MRQ) | ₹318.00 | ₹20.72 |
Financial Statements Comparison: Gocl vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GOCLCORP | GRAUWEIL |
|---|---|---|
| Revenue/Sales | ₹1.14B | ₹3.40B |
| Cost of Goods Sold | ₹917.01M | ₹2.00B |
| Gross Profit | ₹227.28M | ₹1.40B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹500.82M | ₹237.20M |
| EBITDA | ₹-280.76M | ₹417.40M |
| Pre-Tax Income | ₹-466.89M | ₹343.50M |
| Income Tax | ₹-53.51M | ₹86.10M |
| Net Income (Profit) | ₹231.19M | ₹257.40M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GOCLCORP | GRAUWEIL |
|---|---|---|
| Cash & Equivalents | ₹222.72M | ₹1.08B |
| Total Current Assets | ₹18.67B | ₹9.36B |
| Total Current Liabilities | ₹4.19B | ₹2.97B |
| Long-Term Debt | ₹10.13B | ₹37.30M |
| Total Shareholders Equity | ₹15.76B | ₹9.39B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹586.64M | ₹2.47B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GOCLCORP | GRAUWEIL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GOCLCORP | GRAUWEIL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 76,862 | 141,218 |
| Average Daily Volume (90 Day) | 102,275 | 163,561 |
| Shares Outstanding | 49.57M | 453.41M |
| Float Shares | 11.63M | 127.47M |
| % Held by Insiders | 0.75% | 0.72% |
| % Held by Institutions | 0.01% | 0.00% |
Dividend Analysis & Yield Comparison: Gocl vs Grauer & Weil
| Metric | GOCLCORP | GRAUWEIL |
|---|---|---|
| Last 12-Month Dividend | ₹14.00 | ₹1.00 |
| Last 12-Month Dividend Yield | 3.55% | 1.05% |
| 3-Year Avg Annual Dividend | ₹6.33 | ₹0.58 |
| 3-Year Avg Dividend Yield | 1.59% | 0.45% |
| 3-Year Total Dividends | ₹19.00 | ₹1.73 |
| Ex-Dividend Date | Jul 25, 2025 | Aug 06, 2025 |